BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27470368)

  • 1. HMGA1 facilitates tumor progression through regulating Wnt/β-catenin pathway in endometrial cancer.
    Han X; Cao Y; Wang K; Zhu G
    Biomed Pharmacother; 2016 Aug; 82():312-8. PubMed ID: 27470368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
    Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
    Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.
    Xing J; Cao G; Fu C
    Pathol Oncol Res; 2014 Oct; 20(4):847-51. PubMed ID: 24696416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-214 activates TP53 but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical and colorectal cancer cells.
    Chandrasekaran KS; Sathyanarayanan A; Karunagaran D
    Cell Biochem Funct; 2017 Oct; 35(7):464-471. PubMed ID: 29023799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA1 is induced by Wnt/beta-catenin pathway and maintains cell proliferation in gastric cancer.
    Akaboshi S; Watanabe S; Hino Y; Sekita Y; Xi Y; Araki K; Yamamura K; Oshima M; Ito T; Baba H; Nakao M
    Am J Pathol; 2009 Oct; 175(4):1675-85. PubMed ID: 19729480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpressing of POU2F2 accelerates fracture healing via regulating HMGA1/Wnt/β-catenin signaling pathway.
    Zhang W; Zhao H; Chen K; Huang Y
    Biosci Biotechnol Biochem; 2020 Mar; 84(3):491-499. PubMed ID: 31782345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1.
    Wang L; Yang B; Xu Z; Song X; Gong Z; Xue S; Kong L
    Cell Cycle; 2021 May; 20(9):819-828. PubMed ID: 33858292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 11. MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma.
    Chen P; Xing T; Wang Q; Liu A; Liu H; Hu Y; Ji Y; Song Y; Wang D
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31533968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
    Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
    Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
    Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT.
    Chang X; Liu J; Yang Q; Gao Y; Ding X; Zhao J; Li Y; Liu Z; Li Z; Wu Y; Zuo D
    Biochem Pharmacol; 2023 Jun; 212():115582. PubMed ID: 37146833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between S100A13 and HMGA1 in the modulation of thyroid cancer proliferation and invasion.
    Zhong J; Liu C; Chen YJ; Zhang QH; Yang J; Kang X; Chen SR; Wen GB; Zu XY; Cao RX
    J Transl Med; 2016 Mar; 14():80. PubMed ID: 27008379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Wnt-β-catenin and Pten signalling play distinct roles in endometrial cancer initiation and progression.
    van der Zee M; Jia Y; Wang Y; Heijmans-Antonissen C; Ewing PC; Franken P; DeMayo FJ; Lydon JP; Burger CW; Fodde R; Blok LJ
    J Pathol; 2013 May; 230(1):48-58. PubMed ID: 23288720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
    Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
    J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
    Cao XP; Cao Y; Zhao H; Yin J; Hou P
    Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.